Stattin P - Search Results

1

High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.

Stattin P, Rinaldi S, Biessy C, Stenman UH, Hallmans G, Kaaks R. Stattin P, et al. J Clin Oncol. 2004 Aug 1;22(15):3104-12. doi: 10.1200/JCO.2004.10.105. J Clin Oncol. 2004. PMID: 15284261

2

Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.

Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M. Stattin P, et al. Int J Cancer. 2002 May 1;99(1):124-9. doi: 10.1002/ijc.10313. Int J Cancer. 2002. PMID: 11948503 Free article.

3

Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden).

Lukanova A, Söderberg S, Stattin P, Palmqvist R, Lundin E, Biessy C, Rinaldi S, Riboli E, Hallmans G, Kaaks R. Lukanova A, et al. Among authors: stattin p. Cancer Causes Control. 2002 Aug;13(6):509-16. doi: 10.1023/a:1016392129279. Cancer Causes Control. 2002. PMID: 12195640

4

Rye, lignans and human health.

Hallmans G, Zhang JX, Lundin E, Stattin P, Johansson A, Johansson I, Hultén K, Winkvist A, Aman P, Lenner P, Adlercreutz H. Hallmans G, et al. Among authors: stattin p. Proc Nutr Soc. 2003 Feb;62(1):193-9. doi: 10.1079/pns2002229. Proc Nutr Soc. 2003. PMID: 12749346 Review.

5

Plasma leptin is not associated with prostate cancer risk.

Stattin P, Kaaks R, Johansson R, Gislefoss R, Söderberg S, Alfthan H, Stenman UH, Jellum E, Olsson T. Stattin P, et al. Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):474-5. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12750247 No abstract available.

6

Population-based study of prostate-specific antigen testing and prostate cancer detection in clinical practice in northern Sweden.

Pilebro B, Johansson R, Damber L, Damber JE, Stattin P. Pilebro B, et al. Among authors: stattin p. Scand J Urol Nephrol. 2003;37(3):210-2. doi: 10.1080/00365590310008064. Scand J Urol Nephrol. 2003. PMID: 12775278

7

MRI of the skeleton in prostate cancer staging.

Rydh A, Lundblad M, Ahlström KR, Tavelin B, Stattin P. Rydh A, et al. Among authors: stattin p. Scand J Urol Nephrol. 2003;37(3):222-5. doi: 10.1080/00365590310008091. Scand J Urol Nephrol. 2003. PMID: 12775281

8

Re: Insulin resistance and prostate cancer risk.

Stattin P, Kaaks R. Stattin P, et al. J Natl Cancer Inst. 2003 Jul 16;95(14):1086-7; author reply 1087. doi: 10.1093/jnci/95.14.1086. J Natl Cancer Inst. 2003. PMID: 12865455 No abstract available.

9

Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden.

Palmqvist R, Stattin P, Rinaldi S, Biessy C, Stenling R, Riboli E, Hallmans G, Kaaks R. Palmqvist R, et al. Among authors: stattin p. Int J Cancer. 2003 Oct 20;107(1):89-93. doi: 10.1002/ijc.11362. Int J Cancer. 2003. PMID: 12925961 Free article.

10

Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden.

Stattin P, Palmqvist R, Söderberg S, Biessy C, Ardnor B, Hallmans G, Kaaks R, Olsson T. Stattin P, et al. Oncol Rep. 2003 Nov-Dec;10(6):2015-21. Oncol Rep. 2003. PMID: 14534736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

513 results

Search Page